May 7th 2025
This article is sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck, for which Dr. Ilan Melnick is a paid consultant.
March 14th 2025
In this sponsored video series, review common challenges associated with the treatment of schizophrenia, such as treatment nonadherence and relapse.
November 15th 2024
This article was developed and sponsored in collaboration with Neurocrine Biosciences, Inc. Amy LaCouture, RN, BSN, PMHNP-BC and Linda Trinh, DNP, MPH, FNP-C, PMHNP-BC have been compensated by Neurocrine Biosciences, Inc. to author this article and share their perspectives.
Treatment of the Suicidal Patient
August 29th 2023Patient suicide is both personally challenging and legally complicated for mental health professionals. Are you providing the standard of care? How do you balance confidentiality and family support? When is split treatment justified by reduced liability exposure? Difficult questions — but not impossible. Download this guide, provided by Professional Risk Management Services® (PRMS®), for proven risk management and patient safety approaches.
Subtle Signs: Obstructive Sleep Apnea
September 6th 2018This educational supplement brings you closer to the latest medical understanding of these conditions by reviewing symptoms and causes, summarizing recent clinical trials for treatment of OSA, and discussing the case of a 50-year-old patient with excessive daytime sleepiness.
Smart IOP – A New Kind of Intensive Outpatient Program
April 3rd 2018IOP Redefined. We thought that the value of an IOP for addiction could be so much more. Locked into decades of uninspired routine, it was time to see what would happen if we removed the old premise that you needed to drive to a meeting. Turns out, it changed everything.
2 Commerce Drive
Cranbury, NJ 08512